Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18477 ↗At a glance
Journal article in Alimentary Pharmacology & Therapeutics, 2025. Written by Thomas G Cotter and 11 co-authors. Institution: Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA. Major MEDLINE topics: Health Status Disparities, Healthcare Disparities, Hospitalization, Liver Diseases, Alcoholic. Cited 5 times so far (Crossref); 48 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NIAAA NIH HHS, NIDDK NIH HHS, National Institute on Alcohol Abuse and Alcoholism.
Abstract (original language)
Introduction
Alcohol‐associated liver disease (ALD) disproportionately impacts men, racial and ethnic minorities, and individuals of low socioeconomic status; however, it's unclear how recent increases in ALD burden have impacted these disparities. We aimed to describe trends in racial, ethnic and socioeconomic disparities in alcohol‐associated hospital encounters.
Methods
We conducted a retrospective cohort study of adult hospital encounters with alcohol‐associated diagnoses from three health systems between January 2016 and December 2021. The cohort was divided into three eras: a ‘Historical Era,’ (Oct 2016—June 2018, used only for trends); ‘Era 1’ (July 2018—March 2020); and ‘Era 2’ (April 2020—December 2021). Kaplan Meier and Cox regression analyses were performed to identify factors associated with overall survival.
Results
We identified 19,295 individuals with alcohol‐associated encounters (44.7% White, 29.8% Hispanic, and 21.8% non‐Hispanic Black (NHB) individuals), with a greater increase observed between eras 1 and 2 than the historical era and Era 1 (8.7% vs. 5.0%, p < 0.01). By age and sex, the greatest increases in encounters were observed in the youngest and oldest females but only the oldest males. By race and ethnicity, Hispanic individuals had greater increases in encounters compared to Black and White individuals (14.8% vs. 7.5% and 6.3%, p < 0.01). Older age (aSHR: 1.03, 95% CI: 1.03–1.0), higher MELD (aSHR: 1.08, 95% CI: 1.0–1.09), hepatic encephalopathy (aSHR: 1.42, 95% CI: 1.06–1.90), and hepatocellular carcinoma (HCC) (aSHR: 3.20, 95% CI: 2.29–4.49) were associated with increased mortality.
Conclusion
The highest increases of alcohol‐associated encounters were observed amongst young Hispanic and NHB women, highlighting variation in trends by age, sex, race and ethnicity. These disparities merit further investigation to elucidate underlying mechanisms and develop tailored interventions to improve ALD burden and outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Digestive and Liver Diseases, UT Southwestern Medical Center, Dallas, Texas, USA.
- Department of Internal Medicine, UT Southwestern Medical Centre, Dallas, Texas, USA.
ORCID profiles: Thomas G Cotter, Ahmad Anouti, Sarah R Lieber, Nicole E Rich, Amit G Singal
Funding
- NIAAA NIH HHS
- NIDDK NIH HHS
- National Institute on Alcohol Abuse and Alcoholism
Cite
APA
Cotter, T. G., Anouti, A., Zhang, B., Rady, E. D., Patel, M., Patel, S., Ellis, D. J., Lieber, S. R., Rich, N. E., O'Leary, J. G., Mitchell, M. C., & Singal, A. G. (2025). Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18477
Vancouver
Cotter TG, Anouti A, Zhang B, Rady ED, Patel M, Patel S, et al. Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18477
BibTeX
@article{Cotter2025,
author = {Cotter, Thomas G and Anouti, Ahmad and Zhang, Bill and Rady, Elias D and Patel, Mausam and Patel, Suraj and Ellis, Daniel J and Lieber, Sarah R and Rich, Nicole E and O'Leary, Jacqueline G and Mitchell, Mack C and Singal, Amit G},
title = {Disparities in Alcohol‐Associated Liver Disease Hospital Encounters Amongst a Texas‐Based Cohort of Patients},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18477}
}
EUVIMED